Breast Cancer
Conference Coverage
Patritumab deruxtecan shows promise for breast cancer patients
Preliminary studies show acceptable safety profiles and clinical responses that justify future trials.
Conference Coverage
T-DXd for HER2-low BC: Analysis confirms adverse effects
But T-DXd demonstrates a manageable safety profile consistent with prior reports, says the author of a new paper.
Conference Coverage
BMI has greater impact on survival in younger breast cancer patients
Study of women on endocrine therapy for breast cancer addresses the effects of BMI on survival.
News
Number of cancer survivors with functional limitations doubled in 20 years
The 70% prevalence of functional limitation among survivors in 2018 is nearly twice that of the general population.
News
Study shows higher obesity-related cancer mortality in areas with more fast food
An ecologic study showed a dose-response relationship among measures of food swamp and food desert scores and obesity-related cancer mortality.
News
Adherence to cancer prevention guidance linked with reduced breast cancer recurrence, death risk
The study population included patients diagnosed with triple-negative breast cancer and HER2-positive breast cancer.
News
Cancer pain declines with cannabis use
Lower use of other meds was also seen in patients who used cannabis.
Expert Perspective
Antibody Drug Conjugates: a growing field of targeted therapy for breast cancer
Conference Coverage
Guidelines for assessing cancer risk may need updating
Whole-exome sequencing reveals cancer risk mutations in patients that would not have qualified for testing based on current guidelines.
Conference Coverage
Circulating DNA has promise for cancer detection, but faces challenges
Unnecessary procedures and health care challenges could leave Whites as the primary beneficiaries.